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Abstract
OBJECTIVE: This research was conducted to prove the existence of an anti-fibrosis effect in the ethanol extract of 
Moringa oleifera (MO) leaves on the liver.
MATERIALS AND METHODS: The liver fibrosis rat model was injected with chronic CCl4. The ethanol extract of MO 
leaves was divided into three doses (150, 300, and 600 mg/kg body weight) and given through oral gavage.
RESULTS: The results of the histopathological analysis showed that the administration of MO ethanol extract could 
inhibit liver fibrosis as indicated by lower METAVIR scores than positive control rats. The immunohistochemical 
expression of collagen-1 in MO-fed rats also showed a decrease. The same thing was seen in the double-
immunofluorescence staining analysis of α-SMA and tissue inhibitors of metalloproteinases-1 (TIMP-1), where the 
administration of MO ethanol extract decreased both markers.
CONCLUSIONS: This study concluded that the increase in collagen-1, α-SMA, and TIMP-1 simultaneously caused 
a more severe degree of fibrosis (METAVIR score). The ethanol extract of MO leaves was proven to be able to inhibit 
the progression of liver fibrosis by reducing the expression of all three markers.
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Introduction
Liver fibrosis is the resultant process of liver 
fibrogenesis and fibrosis whose mechanisms are 
very complex. Liver fibrosis is caused by chronic 
inflammation as an effort to repair tissue due to 
prolonged lesions. Repairing the liver tissue results in 
an increase in the percentage of collagen up to 50% [1]. 
These collagen tissues (mainly collagen-I and collagen 
III) are produced by activated hepatic stellate cells 
(a-HSCs) or myofibroblast. Various types of a-HSC/
myofibroblasts produce collagen which is spread 
throughout the liver tissue replacing normal tissue [2]. 
The broad distribution of collagen accumulates and 
leads to fibrotic tissue.
Besides secreting collagen-1, a-HSCs/
myofibroblast is also express tissue inhibitors of 
metalloproteinases-1 (TIMP-1). TIMP-1 inhibits matrix 
metalloproteinase (MMP) activity in degrading the 
extracellular matrix. TIMP-1 also inhibits apoptosis of 
a-HSCs so that these cells survive and continue to 
produce extracellular matrix. The final result of these 
complex series is collagen fiber deposition in the Disse 
space, which forms scar tissue or fibrosis [3], [4]. This 
raises the suspicion that HSC activation plays a central 
role in the progression of liver fibrosis. Thus, inhibiting 
HSC activation or inducing apoptosis of a-HSCs 
is a preventive measure against the progression 
of liver fibrosis. The inhibition of HSC activation is 
thought to increase the fibrinolytic activity and repair 
liver fibrosis [4], whereas the apoptosis of a-HSCs 
encourages the resolution of liver fibrosis [5].
It is well known that HSCs activation has an 
important role in the process of liver fibrogenesis. HSC 
activation is also characterized by the production of 
α-smooth muscle actin (α-SMA) immunoreactivity. 
α-SMA is an actin isoform that stands out among 
vascular smooth muscle cells, but not much role 
in skeletal muscle fibrogenesis [6]. In the liver 
fibrogenesis, the increase in a-SMA occurred through 
the activation of JNK1 and JNK2 [7]. At the liver 
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fibrogenesis conditions, a-SMA has an important role 
in the mobility and contraction of myofibroblasts [8] 
so that it can reach the area of injury in liver tissue. 
The recent studies reported that α-SMA does not only 
have function to myofibroblast contractility but also it 
can transmit signals to the nucleus to regulate collagen 
production. α-SMA can transmit signals to the nucleus 
to regulate collagen production [9].
Clinically, liver fibrosis is an asymptomatic 
condition, but it needs treatment that prevents it from 
developing into cirrhosis or liver cancer. Eliminating 
its etiology is the most effective treatment, but 
not all etiologies can be eliminated. Therefore, 
the administration of anti-fibrosis agents that can 
prevent the progression of liver fibrosis is very 
necessary [10], [11].
Moringa oleifera (MO) has long been known 
to have hepatoprotective properties [12] and to provide 
anti-fibrosis effects [13]. The active compounds 
contained in MO, especially quercetin and kaempferol, 
provide antioxidant effects [14]. Quercetin also has the 
anti-proliferation effect of a-HSCs [15] and can induce 
apoptosis of a-HSCs [16].
It was known that the survival of a-HSCs has 
been regulated by collagen and TIMP-1 [3]. Activated 
HSC expresses collagen and TIMP-1 and both regulate 
survival of a-HSC for extended life. Hence, this study 
aims to prove that the administration of the ethanol 
extract of MO leaves can inhibit liver fibrogenesis by 
decreasing the expression of collagen-1, TIMP-1, and 
α-SMA of HSC in fibrosis model rats.
Materials and Methods
This research is a laboratory experimental 
study with a randomized post-test only controlled group 
design. The study was conducted at the University of 
Brawijaya, Indonesia.
Materials
The materials used in this study include CCl4 
(#820354.0010, MERCK, Schuchardt, Germany), 
corn oil, NaCl 0.9%, ketamine, formalin 10%, anti-α-
SMA rabbit monoclonal antibody (M01072-3), TIMP-1 
mouse monoclonal antibody (sc-21734), and COL1A1 
(sc-25974) goat polyclonal IgG antibody. The materials 
used in the extraction were MO leaves and 96% ethanol 
solvent. The MO leaves used were in the powder form, 
obtained from Materia Medica Batu, Malang, Indonesia. 
The experimental animal used was the male Rattus 
norvegicus Wistar strain, with a body weight (BW) of 
200–300 g obtained from the Rattus Breeding Center 
Singosari, Malang, Indonesia.
Preparation and manufacture of the 
ethanol extract of MO leaves
MO leaf powder of 100 g was extracted with 
900 mL of 96% ethanol, shaken using an orbital shaker 
for 30 min, and left overnight at room temperature 
until it settled. The ethanol extract was filtered using 
Whatman paper No. 42, and then concentrated using 
a rotary evaporator. The concentrated MO extract was 
next dissolved using distilled water and administered 
orally by gavage to rat models at a dose of 150, 300, or 
600 mg/kg BW, according to the treatment group.
Animal model induction of liver fibrosis 
and MO ethanol extracts administration
Rats were divided into five groups: Negative 
control (NC), positive control (PC), treatment-1 (T-1), 
treatment-2 (T-2), and treatment-3 (T-3), with six rats 
per group. The NC group was given 0.9% NaCl injection 
twice a week for 14 weeks. The PC group was given 10% 
(in corn oil, 1:9) CCl4 intraperitoneal injection at a dose 
of 1 cc/kg BW for 12 weeks and continued with 2 cc/kg 
BW for the past 2 weeks. Both positive and NCs were 
administered daily through gavage. The treatment-1, 
treatment-2, and treatment-3 groups were given an 
injection of 10% CCl4 with the same dose and time 
as the PC. The difference in treatment lay in the oral 
administration of the ethanol extract of MO leaves through 
gavage. The duration of administration of the ethanol 
extract of MO leaves was the same as the administration 
of Aquadest to the positive group, which was 14 weeks. 
The dose of MO ethanol extract was 150 mg/kg BW in 
the treatment-1 group, 300 mg/kg BW in the treatment-2 
group, and 600 mg/kg BW in the treatment-3 group. The 
rats were euthanized 48 h after the last CCl4 injection by 
injecting 50 mg/kg BW of ketamine intramuscularly and 
then the liver was isolated. The experimental design of 
this study is depicted in Figure 1. All experimental animal 
treatment procedures referred to the institutional and 
local committee on the care and use of animals of the 
Brawijaya University School of Medicine, Malang, East 
Java, Indonesia (number: No 153/EC/KEPK-S3/06/2018).
Figure 1: Experimental design
Histopathological, immunohistochemical, 
and immunofluorescent analyses of liver tissue
The liver was cut in the median lobe. The 
liver pieces were fixed in 10% neutral formalin and 
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then rehydrated with multilevel ethanol, embedded 
in a paraffin block, cut into 5-μm-thick sections using 
a microtome, and mounted on glass slides. The liver 
sections were dewaxed in xylene, rehydrated in 
stratified ethanol for 2–3 min at each concentration, and 
then washed with distilled water. Next, the slide was 
stained with Masson’s trichrome (MT) reagent following 
the standard steps in the procedure. Microscopic fields 
in all sections of the liver were selected randomly for 
testing using a light microscope Olympus BX51.
The degree of liver fibrosis was analyzed by two 
anatomic pathologists. A Metavir score was used to assist 
the fibrosis degree, where F0 is normal tissue; F1: Fibrosis 
limited to the porta, perisinusoidal, and intralobular areas; 
F2: Fibrosis in several portal areas, a fibrous septum is 
formed between the portals, and intralobular architecture 
damage occurs; F3: A fibrous portal–central septum occurs, 
accompanied by damage to the intralobular structure, and 
cirrhosis has not been seen; and F4: cirrhosis [17].
Collagen-1 expression (Santa Cruz 
Biotechnology, sc-25974) in liver tissue was analyzed 
by immunohistochemistry. Slides of liver tissue were 
depolished and rehydrated in alcohol. Incubation was 
carried out using COL1A1 goat polyclonal antibody (1:50) 
at 5°C overnight as the primary antibody and continued 
with peroxidase labeling using the UltraTek HRP anti-
polyvalent (DAB) Staining System (ScyTek Laboratories 
Inc.) kit. The slides were countered using hematoxylin. 
The slide was then scanned using the Olympus BX51 
light microscope. Collagen-1 expression was calculated 
using the manual counting method at ×400 in ten visual 
fields, using image raster 3.0 software.
Double-immunofluorescence staining was 
carried out using TIMP-1 mouse monoclonal antibody 
(Santa Cruz Biotechnology, sc-21734) and anti-α-SMA 
rabbit monoclonal antibody (Boster Biological Technology, 
M01072-3). Slides were pretreated with BSA for 1 h at 
room temperature and incubated with primary antibodies 
(1:500) overnight at 4°C. Slides were then incubated with 
goat anti-mouse IgG rhodamine-conjugated antibody 
and anti-rabbit IgG FITC-conjugated antibody (Rockland 
Immunochemicals) as secondary antibodies for 1 h at 
room temperature. The slides were then countered 
using 4’,6-diamidino-2-phenylindole and washed with 
phosphate-buffered saline. The observations were 
made using the FSX-100 microscope and the number of 
TIMP-1 and α-SMA expressions was counted manually 
with Image Raster 3.0 software.
Statistical analysis
The results of the study are presented as the 
mean and standard deviation. Statistical analysis uses 
one-way ANOVA, followed by Tukey’s post hoc test for 
parametric data or the Kruskal–Wallis test, followed 
by the Mann–Whitney U-test for non-parametric data. 
Correlations were assessed using Pearson’s test for 
parametric data and Spearman’s test for non-parametric 
data. The processing of research data was analyzed 
by computer using Statistical Package for the Social 
Sciences software, IBM SPSS Statistics 22, with a 
significance level at p < 0.05.
Results
Histopathological examination of liver tissue
Histopathological changes in liver tissue 
were seen based on the results of staining with MT 
(Figure 2). All rats in the NC group showed F0 fibrosis, 
whereas all rats in the PC and T-1 groups showed F3 
fibrosis (Table 1). On examining the T-2 group, one rat 
had a degree of F2 fibrosis and the remaining showed 
a degree of F3 fibrosis. On examining the T-3 group, 
four rats showed F2 fibrosis and the remaining two 
rats showed F1 fibrosis. These data correspond to the 
macroscopic picture of the rat liver, where rats with 
the highest degree of fibrosis (PC) showed a pale liver 
color compared to the NC rats and all three treatment 
groups (Figure 3).
Figure 2: Histology of liver tissue by Masson’s trichrome staining 
in rats of (a) negative control, (b) positive control, (c) treatment-1, 
(d) treatment-2, and (e) treatment-3 groups
dcba e
It appears that the Metavir score of the 
treatment group decreases along with the large dose of 
MO ethanol extract given.
Table 1: The degree of liver fibrosis (Metavir score)
Group Degree of fibrosis
F0 F1 F2 F3
Negative control 6 - - -
Positive control - - - 6
Treatment-1 - - - 6
Treatment-2 - - 1 5
Treatment-3 - 2 4 -
The liver of the PC group appears paler and 
wrinkled compared to that of the NC group. In the treatment 
group, T-1 was paler and more wrinkled than T-2 and T-3, 
whereas T-2 was paler and more wrinkled than T-3.
Figure 3: Macroscopic picture of liver in (a) negative control, (b) positive 
control, (c) treatment-1, (d) treatment-2, and (e) treatment-3 groups
dcba e
Immunohistochemical examination of 
collagen-1 expression
The calculation of cells expressing collagen-1 
in the liver used the manual counting method on the 
immunohistochemical preparations by two observers 
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independently. The amount of collagen-1 expression 
was determined based on the ratio between the number 
of hepatocyte cells and HSCs expressing collagen-1 with 
the total number of hepatocytes and HSCs in five visual 
fields with ×400. The final number of cells with collagen-1 
expression in liver tissue is the average of the calculation 
results of the two observers. A description of collagen-1 
expression in the liver per group is shown in Figure 4.
Figure 5: Collagen-1 expression in the liver tissue of each group. The 
expression of collagen-1 in the treatment group decreased along with 
the large dose of MO ethanol extract given. ◊◊◊p < 0.05 versus positive 
control (PC); ***p < 0.05 versus negative control; ◊◊p > 0.05 versus PC
From Figure 5, it can be seen that CCL4 
induction significantly increases the expression of 
collagen-1 in the liver (p = 0.000) and the administration 
of MO ethanol extract can reduce the expression of 
collagen-1. A dose of 150 mg/kg BW (T-1) could reduce 
the expression of collagen-1 to 19.69% from 20.71%. 
The dose of 300 mg/kg BW (T-2) was able to reduce the 
expression of collagen-1 (15.11%) more than T-1, but 
statistically, it was not significantly different (p = 0.164). 
Significant differences occurred only at a dose of 
600 mg/kg BW (T-3), where the mean expression of 
collagen-1 decreased to 9.24% (p = 0.000).
Green arrows indicate liver stellate cells, red 
arrows indicate liver stellate cells that express collagen-1, 
black arrows indicate hepatocyte cells, and blue arrows 
indicate hepatocyte cells that express collagen-1.
Double-immunofluorescence staining of 
TIMP-1 and α-SMA
TIMP-1 and α-SMA expressions were seen 
based on the results of the double-immunofluorescence 
staining of TIMP-1 with α-SMA (Figure 6). TIMP-1 and 
α-SMA expressions showed the same trend with the 
results of the analysis of the fibrosis degree in the liver 
tissue; where both expressions decreased with the 
increasing dose of MO ethanol extract (Figures 7 and 8).
Figure  6:  Microscopic  features  showing  α-smooth  muscle  actin 
colocalization with tissue inhibitors of metalloproteinases-1 with 
indirect immunofluorescence staining: (a) Negative control; (b) positive 
control; (c) treatment-1; (d) treatment-2; and (e) treatment-3
eb
da
c
Discussion
CCl4 is a substance that was often used to induce 
hepatocyte injury to make liver fibrosis animal models. 
Chronic induction of CCL4 results in a progressive loss of 
liver function caused by chronic inflammation that triggers 
a prolonged process of fibrogenesis [18]. In this study, 
CCl4 induction for 14 weeks resulted in Metavir F3 of liver 
fibrosis in all animals model (Table 1). Macroscopically, 
it appears that the liver organ in the control group looks 
pale and wrinkled compared to the negative group or 
other groups (Figure 3). CCl4 is metabolized in the liver by 
cytochrome P450 to form of trichloromethyl radical (CCl3). 
This radical material damage nucleic acids, proteins, and 
Figure 7: The average number of cells expressing tissue inhibitors of 
metalloproteinases-1 in liver tissue: ◊◊◊p < 0.05 versus positive control (PC); 
***p < 0.05 versus negative control; ◊◊p > 0.05 versus PC (not significant)
Figure 4: Expression of collagen-1 in liver tissue of (a) negative 
control, (b) positive control, (c) treatment-1, (d) treatment-2, and 
(e) treatment-3 groups
dc
ba
e
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lipids, lead to disruption of cellular processes. Another 
radical, trichloromethylperoxy radicals (CCl3OO) induce 
CCl3 oxygenation which initiates lipid peroxidation and 
destruction of unsaturated fatty acids. This mechanism 
causes a decrease in membrane permeability 
throughout the cellular compartment and liver damage 
that is characterized by inflammation and fibrosis 
tissue [18]. In fact, the mechanism of CCl4 in causing 
liver fibrosis is very complex, and requires further 
research [19].
Figure 8: The average number of cells expressing α-SMA in the liver: 
◊◊◊p < 0.05 versus positive control (PC); ***p < 0.05 versus negative 
control (NC); **p < 0.05 versus NC
Collagen-1 is the main collagen in liver 
fibrosis tissue. Collagen is produced by active HSCs 
(a-HSCs) and is partly responsible for HSC survival. 
Increased expression of collagen contributes to 
apoptosis-resistant a-HSC [20]. This study proves 
that in liver fibrosis conditions (PC), there is an 
increase in collagen-1 expression. The results of 
this study are in accordance with the results of 
previous research, where the induction of CCL4 can 
significantly increase the number of cells expressing 
collagen-1. This previous research shows that the 
repeated administration of CCL4 injection to rat 
liver fibrosis model can increase the expression of 
collagen-1 [13]. The administration of MO can reduce 
these expressions (Figure 4). The decrease in the 
collagen expression was in accordance with the 
increase in the dose of MO given. Administration of 
MO with doses 600 mg/kg BW was able to significantly 
reduce collagen-1 expression compared to the control 
group. These MO effect was also the same as the 
Hamza’s research [13].
Liver fibrosis tissue is characterized by 
extracellular matrix deposition. Collagen and other 
extracellular material components accumulate and 
damage the normal structure of the liver parenchyma 
and vasculature. Thus, one of the mechanisms of anti-
fibrosis agents is inactivating the a-HSCs. Inactivation 
of a-HSCs causes a reduction in collagen-1 production 
and increased fibrinolysis activity [4]. In our study, 
there is a significant correlation between dosage and 
collagen reduction (Figure 9). This indicates that MO 
has an anti-fibrosis effect which may be associated 
with decreased collagen expression. This study also 
showed that in liver fibrosis rats, there was a significant 
increase in α-SMA (as a marker of a-HSCs), and 
decreased after MO was given (Figure 8). This provides 
evidence that one of the anti-fibrosis mechanisms of 
MO is inactivating a-HSC.
In the process of liver fibrogenesis cannot be 
separated from the role of TIMP-1, which is expressed 
by a-HSC. TIMP-1 is a regulator of extracellular 
matrix protein remodeling. TIMP-1 is thought to be 
involved in the process of fibrogenesis by preventing 
collagen degradation due to MMP inhibitory effects 
and preventing a-HSC apoptosis [21]. In this study, 
TIMP-1 expression was calculated by double-
immunofluorescence staining in cells expressing 
α-SMA. TIMP-1 expression that colocalized with 
α-SMA shows that TIMP-1 is expressed by a-HSCs 
(Figure 6). The number of TIMP-1 expressions in 
the positive group increased significantly, and then 
gradually decreased after the ethanol extract of MO 
leaves was given (Figure 7). When this result was 
associated with improvement in the degree of fibrosis 
in the group given MO (Table 1), the reduction of 
TIMP-1 is additional evidence that MO has a potential 
mechanism to inhibit liver fibrogenesis through 
decreasing the amount of a-HSC.
Considering the anti-apoptotic effects of 
TIMP-1, this study proves that the increased expression 
of TIMP-1 causes a-HSCs to survive and produce more 
collagen-1, thereby lead to liver fibrosis. The ethanol 
extract of MO leaves proved to be able to inhibit 
fibrogenesis by reducing TIMP-1 expression. The anti-
fibrosis mechanism is thought to originate from the 
antioxidant and anti-inflammatory effects of MO. The 
compounds in MO, such as quercetin and kaempferol, 
are compounds that have hydroxyl complexes. The 
hydroxyl complex easily donates electrons to other 
unstable atoms (such as free radicals), stabilizing, and 
neutralizing potential pathological effects. Quercetin is 
considered a powerful antioxidant because of its ability 
to capture free radicals and bind metal ions [15], [22]. 
In this study, we found that the Metavir scores, α-SMA, 
TIMP-1, and collagen-1 expressions showed the same 
trend, which decreased with the increasing doses of 
ethanol extracts of MO leaves.
Figure 9: Correlation graph of Moringa oleifera ethanol extract dose 
versus collagen-1 expression in the liver tissue
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Conclusion
This study concluded that the ethanol extract 
of MO leaves has anti-fibrosis properties by inhibiting 
the progression of liver fibrosis through a decreased 
expression of collagen-1, TIMP-1, and α-SMA. α-SMA 
is not only a a-HSC marker but it also has an important 
role in regulating collagen production. It can be 
suspected that MO can inhibit the progression of liver 
fibrogenesis by decreasing the amount of a-HSCs. For 
that, further research is needed.
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